Dana E. Angelini

1.3k total citations
41 papers, 499 citations indexed

About

Dana E. Angelini is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Dana E. Angelini has authored 41 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Internal Medicine, 9 papers in Cardiology and Cardiovascular Medicine and 9 papers in Oncology. Recurrent topics in Dana E. Angelini's work include Venous Thromboembolism Diagnosis and Management (28 papers), Diagnosis and Treatment of Venous Diseases (6 papers) and Cancer Treatment and Pharmacology (5 papers). Dana E. Angelini is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (28 papers), Diagnosis and Treatment of Venous Diseases (6 papers) and Cancer Treatment and Pharmacology (5 papers). Dana E. Angelini collaborates with scholars based in United States, India and Netherlands. Dana E. Angelini's co-authors include Alok A. Khorana, Keith R. McCrae, Tomas Radivoyevitch, Suman L. Sood, Barbara A. Konkle, Aaron T. Gerds, Christian Nasr, Sudipto Mukherjee, Aziz Nazha and David J. Adelstein and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Dana E. Angelini

37 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana E. Angelini United States 13 211 139 137 95 75 41 499
R.H. WHITE United States 5 487 2.3× 356 2.6× 138 1.0× 92 1.0× 46 0.6× 6 603
J van der Meer Netherlands 5 166 0.8× 81 0.6× 152 1.1× 100 1.1× 29 0.4× 7 404
T. Eng Gan Australia 11 87 0.4× 102 0.7× 133 1.0× 53 0.6× 79 1.1× 29 476
Jean Chidiac France 11 172 0.8× 152 1.1× 62 0.5× 62 0.7× 72 1.0× 23 371
Chiara Ambaglio Italy 12 131 0.6× 95 0.7× 261 1.9× 47 0.5× 39 0.5× 21 415
Silvia Crestani Italy 12 98 0.5× 57 0.4× 424 3.1× 59 0.6× 43 0.6× 21 628
H Ljungnér Sweden 9 231 1.1× 158 1.1× 253 1.8× 126 1.3× 20 0.3× 22 566
T Barbui Italy 12 107 0.5× 68 0.5× 271 2.0× 74 0.8× 32 0.4× 33 489
Andrei Braester Israel 13 94 0.4× 61 0.4× 84 0.6× 58 0.6× 129 1.7× 63 625
Lee Re United States 13 102 0.5× 81 0.6× 33 0.2× 154 1.6× 146 1.9× 23 739

Countries citing papers authored by Dana E. Angelini

Since Specialization
Citations

This map shows the geographic impact of Dana E. Angelini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana E. Angelini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana E. Angelini more than expected).

Fields of papers citing papers by Dana E. Angelini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana E. Angelini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana E. Angelini. The network helps show where Dana E. Angelini may publish in the future.

Co-authorship network of co-authors of Dana E. Angelini

This figure shows the co-authorship network connecting the top 25 collaborators of Dana E. Angelini. A scholar is included among the top collaborators of Dana E. Angelini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana E. Angelini. Dana E. Angelini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patell, Rushad, Dana E. Angelini, Jordan K. Schaefer, et al.. (2025). Patient-centered management of heavy menstrual bleeding while on anticoagulation: A survey study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 313. 114650–114650.
2.
Li, Hong, et al.. (2024). Venous Thromboembolism Post-allogeneic Hematopoietic Cell Transplant: Risk Factors, Incidence, and Outcomes. Thrombosis and Haemostasis. 125(2). 155–162. 3 indexed citations
3.
4.
Angelini, Dana E. & Alok A. Khorana. (2022). Building a CAT clinic - real-world systems approaches to prevention and treatment. Thrombosis Research. 213. S84–S86. 2 indexed citations
5.
Gupta, Shilpa, C.A. Reddy, Dana E. Angelini, et al.. (2022). Thromboembolism in Patients with Metastatic Urothelial Cancer Treated with Immune Checkpoint Inhibitors. Targeted Oncology. 17(5). 563–569. 9 indexed citations
6.
Angelini, Dana E., Scott Kaatz, Rachel Rosovsky, et al.. (2022). COVID‐19 and venous thromboembolism: A narrative review. Research and Practice in Thrombosis and Haemostasis. 6(2). e12666–e12666. 22 indexed citations
7.
Covut, Fahrettin, Sanchit Chawla, Christy Samaras, et al.. (2021). Validation of the IMPEDE VTE score for prediction of venous thromboembolism in multiple myeloma: a retrospective cohort study. British Journal of Haematology. 193(6). 1213–1219. 25 indexed citations
8.
Angelini, Dana E. & Alok A. Khorana. (2021). Publisher note. Thrombosis Research. 208. 173–175. 2 indexed citations
9.
Chatterjee, Victor, Shadi Swaidani, Ravi Kumar Alluri, et al.. (2021). Polyphosphate expression by cancer cell extracellular vesicles mediates binding of factor XII and contact activation. Blood Advances. 5(22). 4741–4751. 24 indexed citations
10.
Gupta, Shilpa, C.A. Reddy, Dana E. Angelini, et al.. (2021). Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy. Targeted Oncology. 16(6). 813–821. 9 indexed citations
11.
Angelini, Dana E., et al.. (2021). Updated guidelines for immune thrombocytopenic purpura: Expanded management options. Cleveland Clinic Journal of Medicine. 88(12). 664–668. 11 indexed citations
12.
Pugliese, Francesca, et al.. (2020). Pharmacoeconomic management of patient with severe asthma in the Emergency Department: retrospective multicentric and cost of illness study. SHILAP Revista de lepidopterología. 5 indexed citations
13.
Devata, Sumana, Dana E. Angelini, Susan Blackburn, et al.. (2020). Use of GMI‐1271, an E‐selectin antagonist, in healthy subjects and in 2 patients with calf vein thrombosis. Research and Practice in Thrombosis and Haemostasis. 4(2). 193–204. 16 indexed citations
14.
Jia, Xuefei, et al.. (2019). Clinical outcomes of isolated distal deep vein thrombosis versus proximal venous thromboembolism in cancer patients: The Cleveland Clinic experience. Journal of Thrombosis and Haemostasis. 18(3). 651–659. 19 indexed citations
15.
Jain, Prantesh, Yu‐Wei Chen, Bhumika Patel, et al.. (2019). Implementation of an electronic medical record tool for early detection of deep vein thrombosis in the ambulatory oncology setting. Research and Practice in Thrombosis and Haemostasis. 3(2). 226–233. 13 indexed citations
16.
Patel, Bhumika, Sagar S. Patel, Dana E. Angelini, et al.. (2017). Implementation of an Electronic Medical Record Tool for Early Detection of Deep Vein Thrombosis in the Ambulatory Oncology Setting: The Cleveland Clinic Experience. Blood. 130. 3361–3361. 2 indexed citations
17.
Rahman, Shafia, Dana E. Angelini, Paul Elson, et al.. (2017). Treatment of Cancer Associated Venous Thrombosis; The Cleveland Clinic Experience. Blood. 130. 4633–4633. 3 indexed citations
18.
Molenaar, Remco J., Christopher Pleyer, Tomas Radivoyevitch, et al.. (2017). Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine. Leukemia. 32(4). 952–959. 20 indexed citations
19.
Devata, Sumana, Suman L. Sood, William G. Kramer, et al.. (2015). First in Human Phase 1 Single Dose Escalation Studies of the E-Selectin Antagonist GMI-1271 Show a Favorable Safety, Pharmacokinetic, and Biomarker Profile. Blood. 126(23). 1004–1004. 15 indexed citations
20.
Angelini, Dana E., Barbara A. Konkle, & Suman L. Sood. (2015). Aging among persons with hemophilia: contemporary concerns. Seminars in Hematology. 53(1). 35–39. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R.H. WHITE Breakdown of academic impact, for papers by J van der Meer Breakdown of academic impact, for papers by T. Eng Gan Breakdown of academic impact, for papers by Jean Chidiac Breakdown of academic impact, for papers by Chiara Ambaglio Breakdown of academic impact, for papers by Silvia Crestani Breakdown of academic impact, for papers by H Ljungnér Breakdown of academic impact, for papers by T Barbui Breakdown of academic impact, for papers by Andrei Braester Breakdown of academic impact, for papers by Lee Re
Rankless by CCL
2026